Cytiva(原GE醫療生命科學事業部)
Cytiva(思拓凡)的前身是GE醫療生命科學事業部,現在隸屬于丹納赫集團旗下的生命科學平臺
作為全球生命科學領域的領先者,Cytiva(思拓凡)致力于促進與加速全球醫療的發展。Cytiva(思拓凡)年銷售額超過33億美元,,并在全球40多個國家擁有近7000名員工。作為值得信賴的合作伙伴,Cytiva(思拓凡)全面助力客戶提升研究與生產流程中的速度、效率與能力,賦能創新型藥物的發展和生產,惠及全球患者。
Cytiva(思拓凡)擁有多樣性的產品組合,其中包括倍受認可的?KTA、Amersham、Biacore、FlexFactory、HyClone、MabSelect、Sefia、Whatman、Xcellerex 和 Xuri 等品牌。這些產品包含了儀器設備、耗材、數字化和企業解決方案,以及為滿足客戶需求而定制的從研究、工藝開發到全生產流程的服務。
Our customers undertake life-saving activities ranging from fundamental biological research to developing innovative vaccines, biologic drugs, and novel cell and gene therapies. Our job is to supply the tools and services they need to work better, faster and safer, leading to better patient outcomes.Cytiva is a global provider of technologies and services that advance and accelerate the development and manufacture of therapeutics. Formerly part of GE Healthcare Life Sciences, we have a rich heritage tracing back hundreds of years, and a fresh beginning since 2020.
Cytiva is a 3.3 billion USD global life sciences leader with over 7000 associates across 40 sites who are dedicated to our vision to improve access to life-changing therapies that transform human health. As a trusted partner to customers that range in scale and scope, Cytiva brings efficiencies to research and manufacturing workflows, ensuring the development, manufacture and delivery of transformative medicines to patients.